Overview of Delorean Corporation's Q4 FY2024 activities report

Delorean Corporation Limited (ASX: $DEL) has reported a strong finish to the FY2024 financial year, with a focus on bioenergy infrastructure projects and profit guidance. The company's annual profit guidance for FY2024 includes an expected EBITDA of between $4.5m and $5.1m, revenue of between $27m and $28m, and a record NPAT for the year. Delorean also highlighted its current cash balance of $8.8m as at 30 June 2024, and the refund of $4.7m in historic Large Scale Generation Certificates (LGC) shortfall charges from the Clean Energy Regulator, contributing to the profit guidance and paying down its loan with Roadnight Capital to $1.1m at 30 June 2024.

Executive commentary on Q4 FY2024 activities

Delorean Corporation is pleased to announce the successful completion of the FY2024 financial year, marked by significant progress in construction delivery, financial performance, and project investment. Our focus on bioenergy infrastructure projects has been instrumental in driving the company's growth trajectory and creating sustained value. The appointment of Neil Conquest as the new Chief Operating Officer further strengthens our leadership team and supports our transition to a Build Own Operate infrastructure model. We are excited about the ongoing demand for our renewable natural gas product and the potential for future growth in the bioenergy sector.

Summary of Q4 FY2024 activities and outlook

Delorean Corporation's Q4 FY2024 activities report reflects a strong performance, with a focus on bioenergy infrastructure projects and profit guidance for FY2024. The company's ambitions to develop, construct, own, and operate bioenergy infrastructure in Australia are supported by a robust pipeline of projects and a proven track record in delivering successful bioenergy projects. Delorean's commitment to sustainability and its ESG credentials position it well to capitalize on the national drive towards zero organic waste to landfill and decarbonization of energy. Looking ahead, Delorean aims to progress its bioenergy infrastructure projects, strengthen its leadership team, and continue its focus on cash flow and profitability in Q1 FY2025.